can anyone help me understand this more.
over the last few years, I have heard it suggested that we could look to seek ATL1102 for 'other indications' to help us fund our trials and get the drug to market, particularly for DMD.
how is a drug sold in the same market for 'other indications'? how does the company ensure that company xyz is only selling this indication and not encroaching on other indication sales?
appreciate you help here. I may have misunderstood what was said but it has been something lingering in my mind.
can anyone help me understand this more.over the last few years,...
-
- There are more pages in this discussion • 1,571 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
